![]() |
Name |
isoechinulin A
|
Molecular Formula | C24H29N3O2 | |
IUPAC Name* |
(3S,6Z)-3-methyl-6-[[2-(2-methylbut-3-en-2-yl)-5-(3-methylbut-2-enyl)-1H-indol-3-yl]methylidene]piperazine-2,5-dione
|
|
SMILES |
C[C@H]1C(=O)N/C(=C\C2=C(NC3=C2C=C(C=C3)CC=C(C)C)C(C)(C)C=C)/C(=O)N1
|
|
InChI |
InChI=1S/C24H29N3O2/c1-7-24(5,6)21-18(13-20-23(29)25-15(4)22(28)27-20)17-12-16(9-8-14(2)3)10-11-19(17)26-21/h7-8,10-13,15,26H,1,9H2,2-6H3,(H,25,29)(H,27,28)/b20-13-/t15-/m0/s1
|
|
InChIKey |
ZHKHUDVCZTVZPU-HYTQYMIGSA-N
|
|
Synonyms |
isoechinulin A; (-)-Isoechinulin A; 7FXA0TK91G; 60422-87-9; (3Z,6S)-3-((2-(1,1-Dimethyl-2-propen-1-yl)-5-(3-methyl-2-buten-1-yl)-1H-indol-3-yl)methylene)-6-methyl-2,5-piperazinedione; 2,5-Piperazinedione, 3-((2-(1,1-dimethyl-2-propen-1-yl)-5-(3-methyl-2-buten-1-yl)-1H-indol-3-yl)methylene)-6-methyl-, (3Z,6S)-; UNII-7FXA0TK91G; CHEMBL250697
|
|
CAS | 60422-87-9 | |
PubChem CID | 44445553 | |
ChEMBL ID | CHEMBL250697 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 391.5 | ALogp: | 5.3 |
HBD: | 3 | HBA: | 2 |
Rotatable Bonds: | 5 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 74.0 | Aromatic Rings: | 3 |
Heavy Atoms: | 29 | QED Weighted: | 0.51 |
Caco-2 Permeability: | -5.087 | MDCK Permeability: | 0.00001440 |
Pgp-inhibitor: | 0.814 | Pgp-substrate: | 0.01 |
Human Intestinal Absorption (HIA): | 0.028 | 20% Bioavailability (F20%): | 0.931 |
30% Bioavailability (F30%): | 0.062 |
Blood-Brain-Barrier Penetration (BBB): | 0.016 | Plasma Protein Binding (PPB): | 99.47% |
Volume Distribution (VD): | 0.24 | Fu: | 1.21% |
CYP1A2-inhibitor: | 0.547 | CYP1A2-substrate: | 0.781 |
CYP2C19-inhibitor: | 0.765 | CYP2C19-substrate: | 0.067 |
CYP2C9-inhibitor: | 0.876 | CYP2C9-substrate: | 0.896 |
CYP2D6-inhibitor: | 0.884 | CYP2D6-substrate: | 0.692 |
CYP3A4-inhibitor: | 0.825 | CYP3A4-substrate: | 0.665 |
Clearance (CL): | 3.162 | Half-life (T1/2): | 0.605 |
hERG Blockers: | 0.062 | Human Hepatotoxicity (H-HT): | 0.796 |
Drug-inuced Liver Injury (DILI): | 0.975 | AMES Toxicity: | 0.004 |
Rat Oral Acute Toxicity: | 0.757 | Maximum Recommended Daily Dose: | 0.118 |
Skin Sensitization: | 0.086 | Carcinogencity: | 0.095 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.014 |
Respiratory Toxicity: | 0.983 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC006144 | ![]() |
0.904 | D0R0MW | ![]() |
0.233 | ||
ENC002460 | ![]() |
0.756 | D0NG7O | ![]() |
0.230 | ||
ENC004457 | ![]() |
0.676 | D0JO3U | ![]() |
0.227 | ||
ENC005569 | ![]() |
0.667 | D0W7WC | ![]() |
0.227 | ||
ENC001957 | ![]() |
0.667 | D01PZD | ![]() |
0.226 | ||
ENC003865 | ![]() |
0.663 | D0O6KE | ![]() |
0.220 | ||
ENC002068 | ![]() |
0.663 | D0Q0PR | ![]() |
0.207 | ||
ENC002447 | ![]() |
0.596 | D0Z6UC | ![]() |
0.207 | ||
ENC004230 | ![]() |
0.573 | D06XZW | ![]() |
0.204 | ||
ENC002895 | ![]() |
0.558 | D01SHZ | ![]() |
0.203 |